News
Paysign, Inc. (PAYS) Q4 2024 Earnings Call Transcript
Paysign, Inc. (NASDAQ:PAYS ) Q4 2024 Earnings Conference Call March 25, 2025 5:00 PM ET Company Participants Mark Newcomer - President and CEO Jeff Baker - CFO Matt Turner - President, Patient Affordability Matt Lanford - CPO Conference Call Participants Jacob Stephan - Lake Street Capital Markets Gary Prestopino - Barrington Research Peter Heckmann - D.A. Davidson Operator Good afternoon.
seekingalpha.com • Mar 25, 2025 18:27 Eastern
Paysign, Inc. Reports Fourth Quarter and Full-Year 2024 Financial Results
HENDERSON, Nev.--(BUSINESS WIRE)--Paysign, Inc. Reports Fourth Quarter and Full-Year 2024 Financial Results.
businesswire.com • Mar 25, 2025 16:03 Eastern
Paysign, Inc. Announces Acquisition of Gamma Innovation's Assets, Appoints Michael Ngo as Chief Innovation Officer
HENDERSON, Nev.--(BUSINESS WIRE)--Paysign, Inc. (NASDAQ: PAYS), a leading provider of patient affordability solutions, financial technology products, and integrated payment processing services, today announced that it has acquired the assets of Gamma Innovation LLC (Gamma), significantly enhancing Paysign's capabilities in plasma donor and pharmaceutical patient engagement technologies. As part of this strategic acquisition, Paysign has appointed Michael Ngo, former Managing Member of Gamma, as.
businesswire.com • Mar 25, 2025 08:05 Eastern
Paysign to Host Fourth Quarter and Full Year 2024 Earnings Call
HENDERSON, Nev.--(BUSINESS WIRE)--Paysign to Host Fourth Quarter and Full Year 2024 Earnings Call.
businesswire.com • Feb 27, 2025 16:30 Eastern
Paysign: Shifting Revenue Mix, Falling Stock, Compelling Opportunity
Paysign, Inc. is a small healthcare-focused Fintech company excelling in the $500M Patient Affordability market, with 230% revenue growth in its Pharma segment over the past four quarters. Despite a 40% stock decline in six months, Paysign's strong fundamentals and innovative solutions present a compelling investment opportunity with a fair value estimate of $3.33 per share. Paysign's strategic focus on Plasma and Patient Affordability programs, vertical integration, and innovation has driven significant growth and improved margins, funded entirely through organic cash flow.
seekingalpha.com • Feb 19, 2025 03:05 Eastern
Paysign Announces 2024 Performance Analysis of Patient Affordability Solutions
HENDERSON, Nev.--(BUSINESS WIRE)--Paysign Announces 2024 Performance Analysis of Patient Affordability Solutions.
businesswire.com • Feb 04, 2025 08:05 Eastern